These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28796411)

  • 1. Progress in Rare Diseases Research 2010-2016: An IRDiRC Perspective.
    Dawkins HJS; Draghia-Akli R; Lasko P; Lau LPL; Jonker AH; Cutillo CM; Rath A; Boycott KM; Baynam G; Lochmüller H; Kaufmann P; Le Cam Y; Hivert V; Austin CP;
    Clin Transl Sci; 2018 Jan; 11(1):11-20. PubMed ID: 28796411
    [No Abstract]   [Full Text] [Related]  

  • 2. Future of Rare Diseases Research 2017-2027: An IRDiRC Perspective.
    Austin CP; Cutillo CM; Lau LPL; Jonker AH; Rath A; Julkowska D; Thomson D; Terry SF; de Montleau B; Ardigò D; Hivert V; Boycott KM; Baynam G; Kaufmann P; Taruscio D; Lochmüller H; Suematsu M; Incerti C; Draghia-Akli R; Norstedt I; Wang L; Dawkins HJS;
    Clin Transl Sci; 2018 Jan; 11(1):21-27. PubMed ID: 28796445
    [No Abstract]   [Full Text] [Related]  

  • 3. The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact.
    Lochmüller H; Torrent I Farnell J; Le Cam Y; Jonker AH; Lau LP; Baynam G; Kaufmann P; Dawkins HJ; Lasko P; Austin CP; Boycott KM;
    Eur J Hum Genet; 2017 Dec; 25(12):1293-1302. PubMed ID: 29158551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of international collaboration for rare diseases research: a European perspective.
    Julkowska D; Austin CP; Cutillo CM; Gancberg D; Hager C; Halftermeyer J; Jonker AH; Lau LPL; Norstedt I; Rath A; Schuster R; Simelyte E; van Weely S
    Gene Ther; 2017 Sep; 24(9):562-571. PubMed ID: 28440796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient groups and biomedicine: for better and for worse.
    Zarocostas J
    Nat Med; 2020 Oct; 26(10):1500-1503. PubMed ID: 33029018
    [No Abstract]   [Full Text] [Related]  

  • 6. The history of the international rare diseases research consortium (IRDiRC) and its conferences.
    Pearce DA
    Eur J Med Genet; 2024 Aug; 70():104935. PubMed ID: 38583555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collaboration and Conflict: Looking Back at the 30-Year History of the AIDS Clinical Trials Group.
    Rubin R
    JAMA; 2015 Dec 22-29; 314(24):2604-6. PubMed ID: 26720014
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rare Diseases].
    Weber S; Grüters-Kieslich A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):477-478. PubMed ID: 28421247
    [No Abstract]   [Full Text] [Related]  

  • 9. [European Reference Network for Rare Neuromuscular Diseases (EURO-NMD). The history behind its constitution and the first steps].
    Evangelista T
    Med Sci (Paris); 2019 Nov; 35 Hors série n° 2():51-54. PubMed ID: 31859636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Global Approach to Rare Diseases Research and Orphan Products Development: The International Rare Diseases Research Consortium (IRDiRC).
    Cutillo CM; Austin CP; Groft SC
    Adv Exp Med Biol; 2017; 1031():349-369. PubMed ID: 29214582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'IRDiRC Recognized Resources': a new mechanism to support scientists to conduct efficient, high-quality research for rare diseases.
    Lochmüller H; Le Cam Y; Jonker AH; Lau LP; Baynam G; Kaufmann P; Lasko P; Dawkins HJ; Austin CP; Boycott KM
    Eur J Hum Genet; 2017 Feb; 25(2):162-165. PubMed ID: 27782107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global effort against rare and orphan diseases.
    Harari S; Cottin V; Humbert M
    Eur Respir Rev; 2012 Sep; 21(125):171-2. PubMed ID: 22941880
    [No Abstract]   [Full Text] [Related]  

  • 13. Implementation of a Rapid Evidence Assessment Infrastructure during the Coronavirus Disease 2019 (COVID-19) Pandemic to Develop Policies, Clinical Pathways, Stimulate Academic Research, and Create Educational Opportunities.
    Rao S; Kwan BM; Curtis DJ; Swanson A; Bakel LA; Bajaj L; Boguniewicz J; Lockwood JM; Ogawa K; Pemberton K; Fuhlbrigge RC; Brumbaugh D; Givens P; Nozik ES; Sills MR
    J Pediatr; 2021 Mar; 230():4-8.e2. PubMed ID: 33091418
    [No Abstract]   [Full Text] [Related]  

  • 14. [Not Available].
    Dollfus H
    Med Sci (Paris); 2016 Apr; 32 Spec No 1():5-7. PubMed ID: 27137853
    [No Abstract]   [Full Text] [Related]  

  • 15. The birth of UNSCEAR--the midwife's tale.
    Appleyard R
    J Radiol Prot; 2010 Sep; 30(3):621-6. PubMed ID: 20826894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International rare cancers initiative.
    Keat N; Law K; Seymour M; Welch J; Trimble T; Lascombe D; Negrouk A
    Lancet Oncol; 2013 Feb; 14(2):109-10. PubMed ID: 23369681
    [No Abstract]   [Full Text] [Related]  

  • 17. Towards the international interoperability of clinical research networks for rare diseases: recommendations from the IRDiRC Task Force.
    Nabbout R; Zanello G; Baker D; Black L; Brambilla I; Buske OJ; Conklin LS; Davies EH; Julkowska D; Kim Y; Klopstock T; Nakamura H; Nielsen KG; Pariser AR; Pastor JC; Scarpa M; Smith M; Taruscio D; Groft S
    Orphanet J Rare Dis; 2023 May; 18(1):109. PubMed ID: 37161573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare diseases band together toward change in research.
    Ainsworth C
    Nat Med; 2020 Oct; 26(10):1496-1499. PubMed ID: 33029019
    [No Abstract]   [Full Text] [Related]  

  • 19. Measuring what matters to rare disease patients - reflections on the work by the IRDiRC taskforce on patient-centered outcome measures.
    Morel T; Cano SJ
    Orphanet J Rare Dis; 2017 Nov; 12(1):171. PubMed ID: 29096663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAC oversight of gene transfer research: a model worth extending?
    King NM
    J Law Med Ethics; 2002; 30(3):381-9. PubMed ID: 12497698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.